Intuitive Surgical price target raised to $650 from $550 at Barrington Barrington raised its price target for Intuitive Surgical shares to $650 saying the new da Vinci Xi system will increase the company's average selling prices and "reinvigorate" its systems revenue. Barrington believes the Street's 2014-2016 estimates for the company are probably too low and keeps an Outperform rating on the stock.
Intuitive Surgical initiated with an Overweight, $575 target at Barclays Barclays analyst Matthew Taylor started shares of Intuitive Surgical with an Overweight rating and $575 price target. Taylor thinks surgery share will continue to shift to robotic and believes demand for Intuitive's da Vinci among general surgeons is very high. The stock closed yesterday down $4.17 to $492.45.